shape Technology Priority shape

Software as a Medical Device (SaMD)
and Low Risk Med-Tech Devices

We are committed to advancing clinical decision-making platforms (devices) as well as investing in low to moderate-risk implantable medical devices (FDA Class I/II)

Committed to Innovation

Our investment strategy reflects a commitment to supporting innovations that directly address actual challenges within the healthcare sector, with an emphasis on practical solutions which will be adopted by practicing clinicians and result in measurable impact.

Software as a Medical Device
Focused on Innovation

Active Patient Engagement Tools

Development of devices and software that encourage patients to actively participate in their care, driving better engagement and compliance with treatment regimens.

Point-of-Care Decision Support

Augmenting clinical decision-making at the point-of-care with advanced AI and data analytics, helping clinicians make more informed decisions in real-time.

Back-end Clinical Decision Support

Tools that enhance clinical delivery by improving backend processes, reducing the cognitive load on clinicians, and optimizing workflow efficiency.

Remote Physiologic Monitoring and Therapeutic Tools

Developing software and devices that extend physician capacity by remotely monitoring patient health and providing real-time therapeutic insights, improving care continuity and patient outcomes.

Wearables and Mobile Health Apps

Expanding the capture of real-time clinical data through wearable devices or mobile health applications, allowing for continuous monitoring of patient health outside the traditional clinical setting.

Dutch Testimonial

Dutch Rojas, Co-Founder Phycap Fund

"Future of medicine must be shaped by those who live it every day"